Cas:171504-98-6 1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate manufacturer & supplier

Chemical Name:1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate

CAS.NO:171504-98-6

Synonyms:1,4-di-tert-butyl methyl piperazine-1,2,4-tricarboxylate;1,4-DI-TERT-BUTYL 2-METHYL PIPERAZINE-1,2,4-TRICARBOXYLATE

Molecular Formula:C₁₆H₂₈N₂O₆

Molecular Weight:344.40300

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:85.38000

Exact Mass:344.19500

LogP:1.89160

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4-di-tert-butyl methyl piperazine-1,2,4-tricarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-DI-TERT-BUTYL 2-METHYL PIPERAZINE-1,2,4-TRICARBOXYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-di-tert-butyl methyl piperazine-1,2,4-tricarboxylate Use and application,1,4-di-tert-butyl methyl piperazine-1,2,4-tricarboxylate technical grade,usp/ep/jp grade.

Related News: The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. 1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate manufacturer If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate supplier A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate vendor A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 1-O,4-O-ditert-butyl 2-O-methyl piperazine-1,2,4-tricarboxylate factory The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.